J. Fröhlich

Apo B versus cholesterol in estimating cardiovascular risk and in guiding therapy: report of the thirty‐person/ten‐country panel

Philip J. Barter, Christie M. Ballantyne, Rafael Carmena et al. · Journal of Internal Medicine · 2006 · 471 citations · Full text

Medicine, Cardiology, Clinical Cardiology +14

Apolipoproteins versus lipids as indices of coronary risk and as targets for statin treatment

AD Sniderman, C.D. Furberg, Anthony Keech et al. · The Lancet · 2003 · 461 citations

Medicine, Biochemistry, Cardiology +14

Genetic and environmental factors affecting the incidence of coronary artery disease in heterozygous familial hypercholesterolemia.

John S. Hill, Michael R. Hayden, J. Fröhlich et al. · Arteriosclerosis and Thrombosis A Journal of Vascular Biology · 1991 · 173 citations

Medicine, Cardiology, Genetics +17

Markedly accelerated catabolism of apolipoprotein A-II (ApoA-II) and high density lipoproteins containing ApoA-II in classic lecithin: cholesterol acyltransferase deficiency and fish-eye disease.

Daniel J. Rader, Katsunori Ikewaki, Nicolas Duverger et al. · Journal of Clinical Investigation · 1994 · 125 citations · Full text

Life Sciences, Biochemistry, Human Genetics +16

High frequency of mutations in the human lipoprotein lipase gene in pregnancy-induced chylomicronemia: possible association with apolipoprotein E2 isoform.

Yuxuan Ma, Teik Chye Ooi, Min LIU et al. · Journal of Lipid Research · 1994 · 119 citations · Full text

Life Sciences, Biochemistry, Molecular Genetics +17